Given the fact that high NF-κB activity was related to resistance to AF in our study in the normal pulmonary organoids, we would advise against combination strategies with NF-κB inhibitors since this might be an important protection mechanism in non-cancerous cells. This evidence concerns the gene NFKB1 and atrial fibrillation.